these in vivo glioma imaging studies , together with related in vitro binding tests , indicate the potential value of monoclonal antiglioma antibodies not only for clinical tumor radioimmunodetection , but also for the evaluation of immunotherapeutic approaches to the glioma disease of man .
C0027651
tumor
C0012634
disease